BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17524230)

  • 1. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
    Yu L; Zeng S
    J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolmitriptan uptake by human intestinal epithelial Caco-2 cells.
    Yu LS; Zhao NP; Yao TW; Zeng S
    Pharmazie; 2006 Oct; 61(10):862-5. PubMed ID: 17069426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
    Sha X; Fang X
    Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxol transport by human intestinal epithelial Caco-2 cells.
    Walle UK; Walle T
    Drug Metab Dispos; 1998 Apr; 26(4):343-6. PubMed ID: 9531522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sinomenine on the in vitro intestinal epithelial transport of selected compounds.
    Lu Z; Chen W; Viljoen A; Hamman JH
    Phytother Res; 2010 Feb; 24(2):211-8. PubMed ID: 19585475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of a hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel, by human intestinal epithelial Caco-2 cells.
    Jiang S; Zu Y; Zhang Y; Fu Y; Wang Z; Wang J
    Planta Med; 2010 Oct; 76(14):1592-5. PubMed ID: 20414861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
    Ma L; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of parthenolide across human intestinal cells (Caco-2).
    Khan SI; Abourashed EA; Khan IA; Walker LA
    Planta Med; 2003 Nov; 69(11):1009-12. PubMed ID: 14735438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers.
    Zheng Y; Yang XW
    Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):704-10. PubMed ID: 18601852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
    He Y; Liu Y; Zeng S
    Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
    He Y; Zeng S
    J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absorption of triterpenoid compounds from Indian bread (Poria cocos) across human intestinal epithelial (Caco-2) cells in vitro].
    Zheng Y; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1596-601. PubMed ID: 18837324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
    Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport characteristics of candesartan in human intestinal Caco-2 cell line.
    Zhou L; Chen X; Gu Y; Liang J
    Biopharm Drug Dispos; 2009 Jul; 30(5):259-64. PubMed ID: 19562680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
    Yamaguchi H; Yano I; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
    Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal permeability of sesquiterpenes in the caco-2 cell monolayer model.
    Wu Q; Zhao B; Yang XW; Xu W; Zhang P; Zou L; Zhang LX
    Planta Med; 2010 Mar; 76(4):319-24. PubMed ID: 19830652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
    Jeong EJ; Lin H; Hu M
    J Pharmacol Exp Ther; 2004 Jul; 310(1):376-85. PubMed ID: 15020665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.